Currently under construction in Ludhiana on over one acre of land, the facility is expected to be operational by December 2026. It is set to redefine manufacturing benchmarks through enhanced precision, scalability, and hygiene.
One of the most compelling aspects of the company’s journey is the entrepreneurial story behind its leadership. Founded in 2015 by brothers Tanishq Dhingra and Tejasvi Dhingra, who began working at the young ages of 17 and 19 respectively, the company started with an initial investment of approximately ₹20,000. Over the past 11 years, it has grown steadily and is now valued at an estimated ₹200–₹250 crores. Their journey reflects resilience, long-term vision, and disciplined execution, transforming a bootstrap venture into a globally expanding enterprise.
The upcoming Ludhiana plant represents a major advancement in India’s nutraceutical manufacturing ecosystem. Designed with end-to-end robotics and automation across the production lifecycle, the facility will significantly reduce human intervention, ensuring higher consistency, improved hygiene standards, and near-zero manufacturing errors.
Globally, robotic manufacturing is increasingly becoming the benchmark in pharmaceutical and nutraceutical production due to its ability to deliver precision at scale. With this initiative, the company is set to elevate India’s manufacturing standards to align with global best practices. Once operational, the plant will substantially increase production capacity, enabling it to meet growing domestic demand while strengthening its export capabilities.
Under the leadership of its co-founders, the company has consistently focused on scientific integrity, high-quality formulations, and operational excellence. This strategic vision is central to the Ludhiana project, ensuring that the new facility becomes a benchmark for advanced manufacturing in the industry.
The company operates through a strategically distributed network, with its primary manufacturing and operational base in Mohali and its corporate office in Gurugram managing business development and partnerships. The addition of the Ludhiana facility will strengthen this ecosystem, creating a robust three-city operational model that supports efficient production, seamless distribution, and stronger collaboration with partners.
It specializes exclusively in sports nutrition and nutraceutical products tailored for athletes, fitness enthusiasts, and performance-focused consumers. Its portfolio includes whey protein, plant-based protein, mass gainers, pre-workouts, amino acid supplements, fat burners, hydration solutions, and ketogenic nutrition products. All products are developed using high-quality raw materials and rigorously vetted suppliers to ensure consistency and trust across domestic and international markets.
A key pillar of the business model is its end-to-end contract manufacturing and white-label services. The company provides turnkey solutions including formulation, sourcing, production, testing, packaging, and logistics. This approach enables fitness entrepreneurs, gym chains, and established nutrition brands to launch and scale products without investing in manufacturing infrastructure. The upcoming robotic facility will further enhance these capabilities through faster turnaround times, higher production volumes, and improved operational reliability.
The company operates under globally recognized certifications such as ISO 9001, GMP, and HACCP, ensuring strict adherence to quality and safety standards. Comprehensive quality checks are implemented at every stage, from raw material sourcing to final packaging. The Ludhiana facility is expected to further elevate these standards through advanced automation, enhancing process control and minimizing variability.
With a presence in over five countries and a client base of more than 500 partners, the company continues to strengthen its global footprint. Supported by industry experience and a growing workforce, its expansion is driven by consistent product quality, regulatory compliance, and reliable supply chain execution. The additional capacity from the Ludhiana plant is expected to accelerate international growth and position India as a competitive hub for nutraceutical manufacturing.
With the launch of this advanced facility, the company has outlined a strong financial and strategic roadmap. By the end of FY 2027–28, it aims to achieve a valuation of ₹500–₹600 crores. This growth will be driven by increased production capacity, expansion into international markets, stronger contract manufacturing partnerships, and enhanced operational efficiency through automation.
Final Strategic Takeaway
Nutro Life Science is entering its next growth phase, where:
• Past 11 years represent foundation building
• Next 3–4 years will focus on aggressive scaling and global positioning
With the robotic plant acting as a catalyst and a clear vision of achieving a ₹500–₹600 crore valuation by FY 2027–28, the company is not just expanding its operations, it is engineering its leadership position in the global sports nutrition industry.
About Nutro Life Science
Nutro Life Science, (Livo Universal Healthcare Pvt Ltd.) is a leading contract manufacturer in the sports nutrition and nutraceutical industry. Founded in 2015, the company operates with its corporate office in Gurugram, Haryana, and its primary manufacturing base in Mohali, Punjab. It specializes in third-party manufacturing and white-label solutions for clients across multiple international markets. Its upcoming robotic manufacturing facility in Ludhiana represents a first-of-its-kind innovation in India’s sports nutrition sector.
.jpeg)
.jpg)
.jpeg)
